93 related articles for article (PubMed ID: 38638823)
1. A cross-sectional study of SARS-CoV-2 antibodies among healthcare workers in a tertiary care hospital in Taiwan: implications for protection against the Omicron variants.
Chen CH; Chao DY; Kor CT; Kuo SF; Lin JS; Lai HW; Liu YT; Lin CH; Chen MK
BMC Infect Dis; 2024 May; 24(1):529. PubMed ID: 38802771
[TBL] [Abstract][Full Text] [Related]
2. Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada.
Rabezanahary H; Gilbert C; Santerre K; Scarrone M; Gilbert M; Thériault M; Brousseau N; Masson JF; Pelletier JN; Boudreau D; Trottier S; Baz M
Heliyon; 2024 May; 10(10):e31026. PubMed ID: 38826717
[TBL] [Abstract][Full Text] [Related]
3. Neutralization antibody titer and change in 50% protection after the third dose of the COVID-19 vaccine.
Mungmunpuntipantip R; Wiwanitkit V
Indian J Pharmacol; 2024 Mar; 56(2):80-83. PubMed ID: 38687310
[TBL] [Abstract][Full Text] [Related]
4. Vaccine Effectiveness against GP-Attended Symptomatic COVID-19 and Hybrid Immunity among Adults in Hungary during the 2022-2023 Respiratory Season Dominated by Different SARS-CoV-2 Omicron Subvariants.
Horváth JK; Túri G; Krisztalovics K; Kristóf K; Oroszi B
Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793747
[TBL] [Abstract][Full Text] [Related]
5. Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain.
de Rioja VL; Basile L; Perramon-Malavez A; Martínez-Solanas É; López D; Medina Maestro S; Coma E; Fina F; Prats C; Mendioroz Peña J; Alvarez-Lacalle E
Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793717
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of SARS-CoV-2 (lineage B.1.1) by hyperimmune llama (Lama glama) serum in vero cell culture.
Yaniro V; Capristano S; Bailon H; Lévano J; Galarza M; García D; Cáceres O; Padilla C; Montejo H; García P; Celis M; Seraylan S; Garayar Y; Palomino M
Rev Peru Med Exp Salud Publica; 2023; 40(3):287-296. PubMed ID: 37991032
[TBL] [Abstract][Full Text] [Related]
7. Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.
Driouich JS; Cochin M; Lingas G; Luciani L; Baronti C; Bernadin O; Gilles M; Villarroel PMS; Moureau G; Petit PR; Dupont A; Izopet J; Kamar N; Autran B; Paintaud G; Caillard S; le Bourgeois A; Richez C; Couzi L; Xhaard A; Marjanovic Z; Avouac J; Jacquet C; Anglicheau D; Cheminant M; Nguyen S; Terrier B; Gottenberg JE; Besson C; Letrou S; Tine J; Basilua JM; Angoulvant D; Tardivon C; Blancho G; Martin-Blondel G; Yazdanpanah Y; Mentré F; Lévy V; Touret F; Guedj J; de Lamballerie X; Nougairède A
Biomed Pharmacother; 2024 Jun; 177():116988. PubMed ID: 38897157
[TBL] [Abstract][Full Text] [Related]
8. Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol.
Campos GRF; Almeida NBF; Filgueiras PS; Corsini CA; Gomes SVC; de Miranda DAP; de Assis JV; Silva TBS; Alves PA; Fernandes GDR; de Oliveira JG; Rahal P; Grenfell RFQ; Nogueira ML
Front Cell Infect Microbiol; 2024; 14():1371695. PubMed ID: 38638823
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
10. Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals.
Kuzel TG; Fu J; Anderson M; Stec M; Boler M; Behun D; Gosha A; Cloherty G; Landay A; Moy J
Vaccine; 2023 Jan; 41(4):879-882. PubMed ID: 36572601
[TBL] [Abstract][Full Text] [Related]
11. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
[TBL] [Abstract][Full Text] [Related]
12. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.
Seidel A; Hoffmann S; Jahrsdörfer B; Körper S; Ludwig C; Vieweg C; Albers D; von Maltitz P; Müller R; Lotfi R; Wuchter P; Klüter H; Kirchhoff F; Schmidt M; Münch J; Schrezenmeier H
Front Immunol; 2023; 14():1170759. PubMed ID: 37180152
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
